IL106156A0 - Pyridinyl compounds - Google Patents
Pyridinyl compoundsInfo
- Publication number
- IL106156A0 IL106156A0 IL106156A IL10615693A IL106156A0 IL 106156 A0 IL106156 A0 IL 106156A0 IL 106156 A IL106156 A IL 106156A IL 10615693 A IL10615693 A IL 10615693A IL 106156 A0 IL106156 A0 IL 106156A0
- Authority
- IL
- Israel
- Prior art keywords
- pct
- sec
- compounds
- pyridinyl compounds
- date jun
- Prior art date
Links
- 125000004076 pyridyl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90677192A | 1992-06-30 | 1992-06-30 | |
| US2519893A | 1993-03-02 | 1993-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL106156A0 true IL106156A0 (en) | 1993-10-20 |
Family
ID=26699422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL106156A IL106156A0 (en) | 1992-06-30 | 1993-06-28 | Pyridinyl compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5990314A (fr) |
| EP (1) | EP0649412B1 (fr) |
| JP (1) | JP3230682B2 (fr) |
| KR (1) | KR950702185A (fr) |
| CN (1) | CN1108247A (fr) |
| AT (1) | ATE231129T1 (fr) |
| AU (2) | AU4545893A (fr) |
| CA (1) | CA2138954A1 (fr) |
| DE (1) | DE69332640T2 (fr) |
| ES (1) | ES2191014T3 (fr) |
| IL (1) | IL106156A0 (fr) |
| MA (1) | MA22926A1 (fr) |
| MX (1) | MX9303973A (fr) |
| NZ (1) | NZ253967A (fr) |
| SI (1) | SI9300349A (fr) |
| WO (1) | WO1994000437A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA945609B (en) | 1993-07-28 | 1995-05-12 | Rhone Poulenc Rorer Ltd | [Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds |
| EP0733044A4 (fr) * | 1993-12-08 | 1997-03-05 | Smithkline Beecham Corp | Composes |
| WO1995015752A1 (fr) * | 1993-12-09 | 1995-06-15 | Smithkline Beecham Corporation | Diphenyl-2-propenoates et leurs homologues, utiles dans le traitement des maladies associees a la leucotriene b4 |
| DK0812194T3 (da) * | 1995-03-02 | 2000-12-18 | Smithkline Beecham Corp | Fremgangsmåde til behandling af atopisk dermatitis og kontaktdermatitis |
| GB9508137D0 (en) * | 1995-04-21 | 1995-06-07 | Smithkline Beecham Plc | Formulation |
| GB9602675D0 (en) * | 1996-02-09 | 1996-04-10 | Smithkline Beecham Plc | Process |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| EP0942903A1 (fr) * | 1996-09-26 | 1999-09-22 | Novartis AG | Acrylamides substitues par de l'aryle ayant une activite antagoniste du recepteur leucotriene b4 (ltb-4) |
| US7361671B2 (en) * | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI925545A0 (fi) * | 1990-06-07 | 1992-12-07 | Smithkline Beecham Corp | Bensoesyraderivat |
| KR930700445A (ko) * | 1990-06-07 | 1993-03-15 | 원본미기재 | 로이코트리엔-관련 질병치료용 벤조산 유도체 |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
-
1993
- 1993-06-28 IL IL106156A patent/IL106156A0/xx unknown
- 1993-06-28 MA MA23216A patent/MA22926A1/fr unknown
- 1993-06-30 DE DE69332640T patent/DE69332640T2/de not_active Expired - Fee Related
- 1993-06-30 SI SI9300349A patent/SI9300349A/sl unknown
- 1993-06-30 CN CN93109519A patent/CN1108247A/zh active Pending
- 1993-06-30 JP JP50265894A patent/JP3230682B2/ja not_active Expired - Fee Related
- 1993-06-30 WO PCT/US1993/006234 patent/WO1994000437A1/fr not_active Ceased
- 1993-06-30 NZ NZ253967A patent/NZ253967A/en unknown
- 1993-06-30 ES ES93915498T patent/ES2191014T3/es not_active Expired - Lifetime
- 1993-06-30 EP EP93915498A patent/EP0649412B1/fr not_active Expired - Lifetime
- 1993-06-30 AT AT93915498T patent/ATE231129T1/de not_active IP Right Cessation
- 1993-06-30 MX MX9303973A patent/MX9303973A/es unknown
- 1993-06-30 AU AU45458/93A patent/AU4545893A/en not_active Abandoned
- 1993-06-30 CA CA002138954A patent/CA2138954A1/fr not_active Abandoned
-
1994
- 1994-12-05 US US08/656,169 patent/US5990314A/en not_active Expired - Lifetime
- 1994-12-29 KR KR1019940704801A patent/KR950702185A/ko not_active Ceased
-
1997
- 1997-05-13 AU AU22807/97A patent/AU707102B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69332640D1 (de) | 2003-02-20 |
| EP0649412A4 (fr) | 1995-07-05 |
| AU4545893A (en) | 1994-01-24 |
| JP3230682B2 (ja) | 2001-11-19 |
| MA22926A1 (fr) | 1994-04-01 |
| KR950702185A (ko) | 1995-06-19 |
| MX9303973A (es) | 1994-04-29 |
| EP0649412B1 (fr) | 2003-01-15 |
| EP0649412A1 (fr) | 1995-04-26 |
| CA2138954A1 (fr) | 1994-01-06 |
| SI9300349A (sl) | 1993-12-31 |
| JPH07508284A (ja) | 1995-09-14 |
| ATE231129T1 (de) | 2003-02-15 |
| DE69332640T2 (de) | 2003-11-06 |
| ES2191014T3 (es) | 2003-09-01 |
| WO1994000437A1 (fr) | 1994-01-06 |
| NZ253967A (en) | 1996-11-26 |
| US5990314A (en) | 1999-11-23 |
| AU2280797A (en) | 1997-08-14 |
| AU707102B2 (en) | 1999-07-01 |
| CN1108247A (zh) | 1995-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9700111D0 (en) | Use of heterocyclic compounds as dopamines-d3 ligands | |
| HU9700109D0 (en) | Triazole compounds and their use as dopamine-d3-ligands | |
| TW263499B (fr) | ||
| IL102188A0 (en) | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
| DE59511017D1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
| KR970704438A (ko) | 티아졸 및 티아디아졸 화합물의 D 도파민 수용체 리간드로서의 용도(Use of Thiazole and Thiadiazole Compounds as D Dopamine Receptor Ligands) | |
| ZA961364B (en) | 1-Aryl-2-acylamino-ethane compounds | |
| SI1077941T1 (sl) | Spojine, ki imajo lastnost sproščanja rastnega hormona | |
| EP0649412A4 (fr) | Composes pharmaceutiques a base de pyridine. | |
| SI1000034T1 (en) | Substituted 6-alkylphenanthridines | |
| GR3031662T3 (en) | Anti-seborrhoeic formulation. | |
| SU860463A1 (ru) | Производные 4-амино-1,3-диметилимидазо [4,5-с] пиридин-2-она, обладающие акарицидным действием | |
| MX9700125A (es) | Compuestos de pirimidina. |